Down syndrome and microRNAs (Review)

  • Authors:
    • Aldina Brás
    • António S. Rodrigues
    • Bruno Gomes
    • José Rueff
  • View Affiliations

  • Published online on: November 17, 2017     https://doi.org/10.3892/br.2017.1019
  • Pages:11-16
Metrics: HTML 0 views | PDF 0 views
0

Abstract

In recent years numerous studies have indicated the importance of microRNAs (miRNA/miRs) in human pathology. Down syndrome (DS) is the most prevalent survivable chromosomal disorder and is attributed to trisomy 21 and the subsequent alteration of the dosage of genes located on this chromosome. A number of miRNAs are overexpressed in down syndrome, including miR‑155, miR‑802, miR‑ 125b‑2, let‑7c and miR‑99a. This overexpression may contribute to the neuropathology, congenital heart defects, leukemia and low rate of solid tumor development observed in patients with DS. MiRNAs located on other chromosomes and with associated target genes on or off chromosome 21 may also be involved in the DS phenotype. In the present review, an overview of miRNAs and the haploinsufficiency and protein translation of specific miRNA targets in DS are discussed. This aimed to aid understanding of the pathogenesis of DS, and may contribute to the development of novel strategies for the prevention and treatment of the pathologies of DS.

Related Articles

Journal Cover

January 2018
Volume 8 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Brás, A., Rodrigues, A.S., Gomes, B., & Rueff, J. (2018). Down syndrome and microRNAs (Review). Biomedical Reports, 8, 11-16. https://doi.org/10.3892/br.2017.1019
MLA
Brás, A., Rodrigues, A. S., Gomes, B., Rueff, J."Down syndrome and microRNAs (Review)". Biomedical Reports 8.1 (2018): 11-16.
Chicago
Brás, A., Rodrigues, A. S., Gomes, B., Rueff, J."Down syndrome and microRNAs (Review)". Biomedical Reports 8, no. 1 (2018): 11-16. https://doi.org/10.3892/br.2017.1019